News & Updates
Filter by Specialty:
Parkinson’s disease: More hours of good on-time with extended- vs immediate-release carbidopa-levodopa
IPX203, a new oral extended-release (ER) carbidopa-levodopa (CD-LD) combination, provides more hours of good on-time per day than immediate-release (IR) CD-LD, according to results of a phase III clinical trial in patients with Parkinson’s disease (PD).
Parkinson’s disease: More hours of good on-time with extended- vs immediate-release carbidopa-levodopa
05 Sep 2023
Infertility treatment carries increased risk of stroke hospitalization
Women who conceive following infertility treatment appear to have a higher likelihood of stroke-related hospitalization within 12 months of delivery as compared with those who spontaneously conceive, according to a study.
Infertility treatment carries increased risk of stroke hospitalization
04 Sep 2023
Female sex protective against obesity-driven dysregulation of glucose metabolism
Insulin sensitivity and secretion differ by sex among Asians without diabetes, reveals a study, noting that female sex is protective on obesity-driven dysregulation of glucose metabolism.
Female sex protective against obesity-driven dysregulation of glucose metabolism
04 Sep 2023
Heart failure, death risks elevated within 10 years after myocardial infarction
Nearly one in three patients with myocardial infarction (MI) develop heart failure or renal failure, while a few of them experience another MI or, worse, die within 10 years, according to a study in England.
Heart failure, death risks elevated within 10 years after myocardial infarction
04 Sep 2023
RT may be omitted after breast-conserving surgery in T1N0, grade 1/2, luminal A breast cancer
Radiotherapy (RT) may be omitted in women ≥55 years of age with T1N0, grade 1 or 2, luminal A breast cancer who have been treated with breast-conserving surgery and endocrine therapy, due to the very low risk of 5-year local recurrence reported in a recent prospective cohort study.